APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Drugs Market Outlook and Growth Opportunities 2026

21 December 2025195 pages

Choose your research edition.

Industry ResearchVeterinary Drugs Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Veterinary Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Veterinary Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Drugs market include Zoetis Inc., Merck Animal Health, Bayer AG, Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., Elanco, Covetrus, Inc. and Ceva Sante Animale S.A., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Veterinary Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Veterinary Drugs market.

Veterinary Drugs Segment by Company

Zoetis Inc.

Merck Animal Health

Bayer AG

Virbac SA

Vetoquinol SA

IDEXX Laboratories, Inc.

Elanco

Covetrus, Inc.

Ceva Sante Animale S.A.

Boehringer Ingelheim Animal Health

Veterinary Drugs Segment by Type

Treatment Drugs

Vaccines

Others

Veterinary Drugs Segment by Application

Chickens

Cattle

Swine

Others

Veterinary Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Veterinary Drugs key companies, revenue, market share, and recent developments.

3. To split the Veterinary Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Veterinary Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Drugs industry.

Chapter 3: Detailed analysis of Veterinary Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Veterinary Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Veterinary Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Drugs Industry Trends Table 2. Veterinary Drugs Industry Drivers Table 3. Veterinary Drugs Industry Opportunities and Challenges Table 4. Veterinary Drugs Industry Restraints Table 5. Global Veterinary Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Drugs Revenue Share by Company (2021-2026) Table 7. Global Veterinary Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Veterinary Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Veterinary Drugs Company, Product Type & Application Table 10. Global Veterinary Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Veterinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Treatment Drugs Table 15. Significant Companies of Vaccines Table 16. Significant Companies of Others Table 17. Global Veterinary Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Veterinary Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Veterinary Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Veterinary Drugs Sales Value Share by Type (2021-2026) Table 21. Global Veterinary Drugs Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Chickens Table 23. Significant Companies of Cattle Table 24. Significant Companies of Swine Table 25. Significant Companies of Others Table 26. Global Veterinary Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Veterinary Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Veterinary Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Veterinary Drugs Sales Value Share by Application (2021-2026) Table 30. Global Veterinary Drugs Sales Value Share by Application (2027-2032) Table 31. Global Veterinary Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Veterinary Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Veterinary Drugs Sales Value Share by Region (2021-2026) Table 34. Global Veterinary Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Veterinary Drugs Sales Value Share by Region (2027-2032) Table 36. Global Veterinary Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Veterinary Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Veterinary Drugs Sales Value Market Share by Country (2021-2026) Table 39. Global Veterinary Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Veterinary Drugs Sales Value Market Share by Country (2027-2032) Table 41. Zoetis Inc. Company Information Table 42. Zoetis Inc. Business Overview Table 43. Zoetis Inc. Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Zoetis Inc. Veterinary Drugs Product Portfolio Table 45. Zoetis Inc. Recent Development Table 46. Merck Animal Health Company Information Table 47. Merck Animal Health Business Overview Table 48. Merck Animal Health Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Merck Animal Health Veterinary Drugs Product Portfolio Table 50. Merck Animal Health Recent Development Table 51. Bayer AG Company Information Table 52. Bayer AG Business Overview Table 53. Bayer AG Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Bayer AG Veterinary Drugs Product Portfolio Table 55. Bayer AG Recent Development Table 56. Virbac SA Company Information Table 57. Virbac SA Business Overview Table 58. Virbac SA Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Virbac SA Veterinary Drugs Product Portfolio Table 60. Virbac SA Recent Development Table 61. Vetoquinol SA Company Information Table 62. Vetoquinol SA Business Overview Table 63. Vetoquinol SA Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Vetoquinol SA Veterinary Drugs Product Portfolio Table 65. Vetoquinol SA Recent Development Table 66. IDEXX Laboratories, Inc. Company Information Table 67. IDEXX Laboratories, Inc. Business Overview Table 68. IDEXX Laboratories, Inc. Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. IDEXX Laboratories, Inc. Veterinary Drugs Product Portfolio Table 70. IDEXX Laboratories, Inc. Recent Development Table 71. Elanco Company Information Table 72. Elanco Business Overview Table 73. Elanco Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Elanco Veterinary Drugs Product Portfolio Table 75. Elanco Recent Development Table 76. Covetrus, Inc. Company Information Table 77. Covetrus, Inc. Business Overview Table 78. Covetrus, Inc. Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Covetrus, Inc. Veterinary Drugs Product Portfolio Table 80. Covetrus, Inc. Recent Development Table 81. Ceva Sante Animale S.A. Company Information Table 82. Ceva Sante Animale S.A. Business Overview Table 83. Ceva Sante Animale S.A. Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Ceva Sante Animale S.A. Veterinary Drugs Product Portfolio Table 85. Ceva Sante Animale S.A. Recent Development Table 86. Boehringer Ingelheim Animal Health Company Information Table 87. Boehringer Ingelheim Animal Health Business Overview Table 88. Boehringer Ingelheim Animal Health Veterinary Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Boehringer Ingelheim Animal Health Veterinary Drugs Product Portfolio Table 90. Boehringer Ingelheim Animal Health Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Veterinary Drugs Product Image Figure 2. Global Veterinary Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Treatment Drugs Image Figure 8. Vaccines Image Figure 9. Others Image Figure 10. Global Veterinary Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Veterinary Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Drugs Sales Value Share by Type (2021-2032) Figure 13. Chickens Image Figure 14. Cattle Image Figure 15. Swine Image Figure 16. Others Image Figure 17. Global Veterinary Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Veterinary Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Veterinary Drugs Sales Value Share by Application (2021-2032) Figure 20. Global Veterinary Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Veterinary Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Veterinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 23. North America Veterinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Veterinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Veterinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Veterinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Veterinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Veterinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 29. South America Veterinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Veterinary Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Veterinary Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Veterinary Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Veterinary Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Veterinary Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Treatment Drugs
  • Vaccines
  • Others
Applications
  • Chickens
  • Cattle
  • Swine
  • Others
Companies covered
  • Zoetis Inc.
  • Merck Animal Health
  • Bayer AG
  • Virbac SA
  • Vetoquinol SA
  • IDEXX Laboratories, Inc.
  • Elanco
  • Covetrus, Inc.
  • Ceva Sante Animale S.A.
  • Boehringer Ingelheim Animal Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Veterinary Drugs Market Dynamics
  1. 2.1 Veterinary Drugs Industry Trends
  2. 2.2 Veterinary Drugs Industry Drivers
  3. 2.3 Veterinary Drugs Industry Opportunities and Challenges
  4. 2.4 Veterinary Drugs Industry Restraints
3 Veterinary Drugs Market by Company
  1. 3.1 Global Veterinary Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Drugs Company Ranking (2024-2026)
  4. 3.4 Global Veterinary Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Veterinary Drugs Company Product Type and Application
  6. 3.6 Global Veterinary Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Veterinary Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Veterinary Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Veterinary Drugs Market by Type
  1. 4.1 Veterinary Drugs Type Introduction
  2. 4.1.1 Treatment Drugs
  3. 4.1.2 Vaccines
  4. 4.1.3 Others
  5. 4.2 Global Veterinary Drugs Sales Value by Type
  6. 4.2.1 Global Veterinary Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Veterinary Drugs Sales Value by Type (2021-2032)
  8. 4.2.3 Global Veterinary Drugs Sales Value Share by Type (2021-2032)
5 Veterinary Drugs Market by Application
  1. 5.1 Veterinary Drugs Application Introduction
  2. 5.1.1 Chickens
  3. 5.1.2 Cattle
  4. 5.1.3 Swine
  5. 5.1.4 Others
  6. 5.2 Global Veterinary Drugs Sales Value by Application
  7. 5.2.1 Global Veterinary Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Veterinary Drugs Sales Value by Application (2021-2032)
  9. 5.2.3 Global Veterinary Drugs Sales Value Share by Application (2021-2032)
6 Veterinary Drugs Regional Value Analysis
  1. 6.1 Global Veterinary Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Veterinary Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Veterinary Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Veterinary Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Veterinary Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Veterinary Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Veterinary Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Veterinary Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Veterinary Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Veterinary Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Veterinary Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Veterinary Drugs Sales Value Share by Country, 2025 VS 2032
7 Veterinary Drugs Country-level Value Analysis
  1. 7.1 Global Veterinary Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Veterinary Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Veterinary Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Veterinary Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Veterinary Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Veterinary Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Veterinary Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Veterinary Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Veterinary Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Veterinary Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Veterinary Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Veterinary Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Veterinary Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Veterinary Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Veterinary Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Veterinary Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Veterinary Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Veterinary Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Veterinary Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Veterinary Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Veterinary Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Veterinary Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Veterinary Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Veterinary Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Veterinary Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Veterinary Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Veterinary Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Veterinary Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Veterinary Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Veterinary Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Veterinary Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Veterinary Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Veterinary Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis Inc.
  2. 8.1.1 Zoetis Inc. Company Information
  3. 8.1.2 Zoetis Inc. Business Overview
  4. 8.1.3 Zoetis Inc. Veterinary Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Inc. Veterinary Drugs Product Portfolio
  6. 8.1.5 Zoetis Inc. Recent Developments
  7. 8.2 Merck Animal Health
  8. 8.2.1 Merck Animal Health Company Information
  9. 8.2.2 Merck Animal Health Business Overview
  10. 8.2.3 Merck Animal Health Veterinary Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Animal Health Veterinary Drugs Product Portfolio
  12. 8.2.5 Merck Animal Health Recent Developments
  13. 8.3 Bayer AG
  14. 8.3.1 Bayer AG Company Information
  15. 8.3.2 Bayer AG Business Overview
  16. 8.3.3 Bayer AG Veterinary Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bayer AG Veterinary Drugs Product Portfolio
  18. 8.3.5 Bayer AG Recent Developments
  19. 8.4 Virbac SA
  20. 8.4.1 Virbac SA Company Information
  21. 8.4.2 Virbac SA Business Overview
  22. 8.4.3 Virbac SA Veterinary Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac SA Veterinary Drugs Product Portfolio
  24. 8.4.5 Virbac SA Recent Developments
  25. 8.5 Vetoquinol SA
  26. 8.5.1 Vetoquinol SA Company Information
  27. 8.5.2 Vetoquinol SA Business Overview
  28. 8.5.3 Vetoquinol SA Veterinary Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol SA Veterinary Drugs Product Portfolio
  30. 8.5.5 Vetoquinol SA Recent Developments
  31. 8.6 IDEXX Laboratories, Inc.
  32. 8.6.1 IDEXX Laboratories, Inc. Company Information
  33. 8.6.2 IDEXX Laboratories, Inc. Business Overview
  34. 8.6.3 IDEXX Laboratories, Inc. Veterinary Drugs Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IDEXX Laboratories, Inc. Veterinary Drugs Product Portfolio
  36. 8.6.5 IDEXX Laboratories, Inc. Recent Developments
  37. 8.7 Elanco
  38. 8.7.1 Elanco Company Information
  39. 8.7.2 Elanco Business Overview
  40. 8.7.3 Elanco Veterinary Drugs Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Elanco Veterinary Drugs Product Portfolio
  42. 8.7.5 Elanco Recent Developments
  43. 8.8 Covetrus, Inc.
  44. 8.8.1 Covetrus, Inc. Company Information
  45. 8.8.2 Covetrus, Inc. Business Overview
  46. 8.8.3 Covetrus, Inc. Veterinary Drugs Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Covetrus, Inc. Veterinary Drugs Product Portfolio
  48. 8.8.5 Covetrus, Inc. Recent Developments
  49. 8.9 Ceva Sante Animale S.A.
  50. 8.9.1 Ceva Sante Animale S.A. Company Information
  51. 8.9.2 Ceva Sante Animale S.A. Business Overview
  52. 8.9.3 Ceva Sante Animale S.A. Veterinary Drugs Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ceva Sante Animale S.A. Veterinary Drugs Product Portfolio
  54. 8.9.5 Ceva Sante Animale S.A. Recent Developments
  55. 8.10 Boehringer Ingelheim Animal Health
  56. 8.10.1 Boehringer Ingelheim Animal Health Company Information
  57. 8.10.2 Boehringer Ingelheim Animal Health Business Overview
  58. 8.10.3 Boehringer Ingelheim Animal Health Veterinary Drugs Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Animal Health Veterinary Drugs Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Animal Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst